Evidence map›Paper›PMID 32896103›Full record

ArticleProteomics2021

Leveraging Immonium Ions for Targeting Acyl-Lysine Modifications in Proteomic Datasets.

John M Muroski, Janine Y Fu, Hong Hanh Nguyen, Rachel R Ogorzalek Loo, Joseph A Loo

Open access · greenAbstract read
In one paragraph

Article in Proteomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Chemoproteomic identification of CONature chemical biology · 2022
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

John M MuroskiDepartment of Chemistry and Biochemistry, University of California, Los Angeles, CA, 90095, USA.
Janine Y FuDepartment of Chemistry and Biochemistry, University of California, Los Angeles, CA, 90095, USA.
Hong Hanh NguyenDepartment of Chemistry and Biochemistry, University of California, Los Angeles, CA, 90095, USA.
Rachel R Ogorzalek LooDavid Geffen School of Medicine, Department of Biological Chemistry, University of California, Los Angeles, CA, 90095, USA.
Joseph A LooDepartment of Chemistry and Biochemistry, University of California, Los Angeles, CA, 90095, USA.ORCID 0000-0001-9989-1437
University of California, Los Angeles · US

Funding

UCLA NIGMS T32 Program AssessmentT32GM007185 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TORRES, JORGE · 1985 to 2020
$21.7M
Impact of Non-canonical Decoding on the ProteomeR01GM085402 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LOO, JOSEPH A, OGORZALEK LOO, RACHEL R. · 2008 to 2011
$1.2M
Mass Spectrometry Imaging of Protein GelsR01GM104610 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LOO, JOSEPH A, OGORZALEK LOO, RACHEL R. · 2012 to 2015
$1.2M
NIGMS NIH HHS R01 GM085402NIGMS NIH HHS R01 GM104610NIGMS NIH HHS T32 GM007185NIH HHS GM007185
6 · The paper itself

Abstract

Acyl modifications vary greatly in terms of elemental composition and site of protein modification. Developing methods to identify acyl modifications more confidently can help to assess the scope of these modifications in large proteomic datasets. The utility of acyl-lysine immonium ions is analyzed for identifying the modifications in proteomic datasets. It is demonstrated that the cyclized immonium ion is a strong indicator of acyl-lysine presence when its rank or relative abundance compared to other ions within a spectrum is considered. Utilizing a stepped collision energy method in a shotgun experiment highlights the immonium ion. By implementing an analysis that accounted for features within each MS

Indexed as

ProteomicsDatasets as TopicIonsLysinePeptidesProtein Processing, Post-TranslationalIonsLysinePeptidesacylationimmonium ions

Identifiers

PMID32896103
PMCPMC8742405
OpenAlexW3084410483

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.